In vitro and in vivo characterization of the antimalarial lead compound SSJ-183 in Plasmodium models.
about
A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malariaCharacterization of Novel Antimalarial Compound ACT-451840: Preclinical Assessment of Activity and Dose-Efficacy ModelingAntimalarial efficacy of MMV390048, an inhibitor of Plasmodium phosphatidylinositol 4-kinase.
P2860
In vitro and in vivo characterization of the antimalarial lead compound SSJ-183 in Plasmodium models.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
In vitro and in vivo character ...... SSJ-183 in Plasmodium models.
@en
In vitro and in vivo character ...... SSJ-183 in Plasmodium models.
@nl
type
label
In vitro and in vivo character ...... SSJ-183 in Plasmodium models.
@en
In vitro and in vivo character ...... SSJ-183 in Plasmodium models.
@nl
prefLabel
In vitro and in vivo character ...... SSJ-183 in Plasmodium models.
@en
In vitro and in vivo character ...... SSJ-183 in Plasmodium models.
@nl
P2093
P2860
P50
P356
P1476
In vitro and in vivo character ...... SSJ-183 in Plasmodium models.
@en
P2093
Christian Scheurer
David M Shackleford
Ian Bathurst
Isamu Itoh
Julia Morizzi
Julie Lotharius
Karen L White
Masataka Ihara
Pascal Fantauzzi
P2860
P304
P356
10.2147/DDDT.S51298
P407
P577
2013-11-15T00:00:00Z